Description: DA32 Life Science Tech Acquisition Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities.
345 Park Avenue South
New York,
NY
10010
United States
Phone:
212 551 1600
Officers
| Name | Title |
|---|---|
| Dr. Steven Kafka Ph.D. | CEO & Director |
| Mr. Christopher E. Wolfe | CFO & Sec. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-07-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |